search
Back to results

Effect of Carbohydrate Distribution on Blood Glucose in Women With Gestational Diabetes Mellitus (GDM)

Primary Purpose

Diabetes, Gestational

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
High/low carbohydrate distribution
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes, Gestational focused on measuring gestational diabetes, carbohydrate distribution, high/low carbohydrate, glycemic variability, MAGE, continuous glucose monitoring, Pregnancy in Diabetics

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Gestational diabetes mellitus diagnosed according to current WHO criteria for a 2-hour oral glucose tolerance test (OGTT) > 8.5 mmol/l
  • Non-insulin depending
  • Adult 18+ years
  • Gestational age weeks 30-36 at start of inclusion

Exclusion Criteria:

  • Diagnosed with celiac disease
  • Received bariatric surgery
  • Diagnosed eating disorder
  • Insulin-dependent diabetes at trial start
  • Known with type 2 diabetes before pregnancy
  • Children under 18 years
  • Starting up in insulin during the intervention period
  • Diagnosed with lactose intolerance
  • Goes into labor before the intervention is completed

Sites / Locations

  • University hospital Aarhus
  • University of Aarhus

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Low-morning-carbohydrate

High-morning-carbohydrate

Arm Description

Low morning intake and high evening intake of carbohydrates. This means a distribution of carbohydrate as follows: 10% morning, 40% lunch, 50% dinner. The overall recommendations for macro- and micronutrient intake for GDM patients will be met.

High morning intake and low evening intake of carbohydrates. This means a distribution of carbohydrate as follows: 50% morning, 40% lunch, 10% dinner. The overall recommendations for macro- and micronutrient intake for GDM patients will be met.

Outcomes

Primary Outcome Measures

mean amplitude of glucose excursions (MAGE)
An index for glycemic variability assessment MAGE is the average variation in amplitude and is calculated as the mean of absolute value differences between adjacent glucose peaks and valleys, where the differences exceed 1 Standard Deviation (SD) from the mean.

Secondary Outcome Measures

Coefficient of variation
Coefficient of variation
MBG
The average blood glucose, calculated for each two intervention periods using CGM data.
Glucagon-like-peptide 1 (GLP1)
glucagon-like-peptide 1, difference in 1 hour postprandial response
Gastric inhibitory polypeptide (GIP)
Gastric inhibitory polypeptide difference in 1 hour postprandial response
C-peptide
Changes in C-peptide according to carbohydrate distribution

Full Information

First Posted
February 7, 2019
Last Updated
September 27, 2019
Sponsor
University of Aarhus
Collaborators
University of Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT03835208
Brief Title
Effect of Carbohydrate Distribution on Blood Glucose in Women With Gestational Diabetes Mellitus (GDM)
Official Title
The Effect of High-morning-carbohydrate Intake Versus Low-morning-carbohydrate Intake on Glycemic Variability Measured by Continuous Glucose Monitoring in GDM Patients - a Randomized Crossover Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 25, 2019 (Actual)
Primary Completion Date
September 27, 2019 (Actual)
Study Completion Date
May 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
University of Copenhagen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims to investigate whether high-morning carbohydrate intake (HMK) compared with low-morning carbohydrate intake (LMK) affects glycemic variability in GDM patients based on Continuous glucose monitoring (CGM). High carbohydrate morning intake is expected to reduce hyperglycemic episodes and stabilize blood glucose compared with low morning carbohydrate intake.
Detailed Description
Background: Women with GDM have an increased risk of macrosomia, cesarean section, birth defects and long term complications such as an increased risk, in both mother and child, to develop type 2 diabetes. According to Invitro and invivo studies of type 1 and 2 diabetes, great variations in blood glucose levels caused more complications than constantly elevated glucose levels. This study, therefore, intends to use Continuous glucose monitoring (CGM) for day-to-day monitoring of glycemic variability, including frequency, duration, and magnitude of hyperglycaemic fluctuations. Carbohydrate is the macronutrient that has the greatest impact on postprandial blood glucose response. Despite this, there is a current lack of evidence of how the carbohydrate intake should be distributed throughout a day. This study aims to investigate whether high-morning carbohydrate intake (HMK) compared to low-morning carbohydrate intake (LMK) affects glycemic variability in GDM patients. Design: Randomized crossover intervention study comparing two intervention diets; high-morning carbohydrate intake (HMK) versus low-morning carbohydrate intake (LMK) each of 3 days duration with four-day washout. Diet intervention: Both intervention diets have the same calorie content and contain the same amounts of protein, carbohydrate and fat for the individual patient, but the distribution of carbohydrate and energy differs throughout the day. Dietary intake will be estimated through 24-hour recall interview by trained dietitians. Estimation of actual intake is validated by photos of every main meal. All data will be collected and stored in RedCap to secure data checks. Statistics Analysis and sample size: Power calculation on primary outcome MAGE- estimates 15 patients for inclusion with a power of 80%, SD 0,6mmol/l, a significance level of 0,05 and a MIREDIF of 0,5 mmol/l. 15 persons include an expected dropout rate at 20%. Non-parametric tests will be used for the secondary and primary outcome. Perspective: A future perspective of this study is to improve the current treatment in regards to nutritional recommendations. Thus, the study could potentially contribute with the knowledge that would clarify the carbohydrate recommendations and improve the glycemic control of patients with GDM and therefore be beneficial to patients' future treatment and prevent complications and development of type 2 diabetes in the child.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Gestational
Keywords
gestational diabetes, carbohydrate distribution, high/low carbohydrate, glycemic variability, MAGE, continuous glucose monitoring, Pregnancy in Diabetics

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Each patient will follow the HMK and LMK diet in a period of 2x3 days in randomized order with a four day washout between. The order of the two diets will be assigned randomly.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low-morning-carbohydrate
Arm Type
Experimental
Arm Description
Low morning intake and high evening intake of carbohydrates. This means a distribution of carbohydrate as follows: 10% morning, 40% lunch, 50% dinner. The overall recommendations for macro- and micronutrient intake for GDM patients will be met.
Arm Title
High-morning-carbohydrate
Arm Type
Experimental
Arm Description
High morning intake and low evening intake of carbohydrates. This means a distribution of carbohydrate as follows: 50% morning, 40% lunch, 10% dinner. The overall recommendations for macro- and micronutrient intake for GDM patients will be met.
Intervention Type
Behavioral
Intervention Name(s)
High/low carbohydrate distribution
Other Intervention Name(s)
High-energy breakfasting compared with high-energy dinner
Intervention Description
A total of 2x3 days, were the patient follow a detailed diet plan. For 3 days they follow a diet plan where the majority of the carbohydrates are located on either the first part of the day(HMK) or the last part of the day(LMK). 4 days of washout are placed between the two interventions. They will not receive food but will be guided by a trained dietitian and the use of a meal plan.
Primary Outcome Measure Information:
Title
mean amplitude of glucose excursions (MAGE)
Description
An index for glycemic variability assessment MAGE is the average variation in amplitude and is calculated as the mean of absolute value differences between adjacent glucose peaks and valleys, where the differences exceed 1 Standard Deviation (SD) from the mean.
Time Frame
6 days
Secondary Outcome Measure Information:
Title
Coefficient of variation
Description
Coefficient of variation
Time Frame
6 days
Title
MBG
Description
The average blood glucose, calculated for each two intervention periods using CGM data.
Time Frame
6 days
Title
Glucagon-like-peptide 1 (GLP1)
Description
glucagon-like-peptide 1, difference in 1 hour postprandial response
Time Frame
1 hour *2
Title
Gastric inhibitory polypeptide (GIP)
Description
Gastric inhibitory polypeptide difference in 1 hour postprandial response
Time Frame
1 hour*2
Title
C-peptide
Description
Changes in C-peptide according to carbohydrate distribution
Time Frame
11 days
Other Pre-specified Outcome Measures:
Title
3-hydroxy-butyrate
Description
To assess ketonemia
Time Frame
11 days

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
pregnant women
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Gestational diabetes mellitus diagnosed according to current WHO criteria for a 2-hour oral glucose tolerance test (OGTT) > 8.5 mmol/l Non-insulin depending Adult 18+ years Gestational age weeks 30-36 at start of inclusion Exclusion Criteria: Diagnosed with celiac disease Received bariatric surgery Diagnosed eating disorder Insulin-dependent diabetes at trial start Known with type 2 diabetes before pregnancy Children under 18 years Starting up in insulin during the intervention period Diagnosed with lactose intolerance Goes into labor before the intervention is completed
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Per G Ovesen, Dr.Med
Organizational Affiliation
Women's diseases and births
Official's Role
Study Director
Facility Information:
Facility Name
University hospital Aarhus
City
Skejby
State/Province
Aarhus N
ZIP/Postal Code
8200
Country
Denmark
Facility Name
University of Aarhus
City
Skejby
State/Province
Aarhus N
ZIP/Postal Code
8200
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Carbohydrate Distribution on Blood Glucose in Women With Gestational Diabetes Mellitus (GDM)

We'll reach out to this number within 24 hrs